Adriana Feder, MD; Oneysha Brown, BA; Sarah B. Rutter, MA; Leah Cahn, LCSW; Jessica R. Overbey, DrPH; Saren H. Seeley, PhD; Alex Yu, MD; Philip A. Bonanno, MD; Rachel A. Fremont, MD, PhD; Andrew A. Delgado, PhD; Manish K. Jha, MD; Sara Costi, MD; Rachel Yehuda, PhD; Daniela Schiller, PhD; Robert H. Pietrzak, PhD, MPH; Dennis S. Charney, MD; Denise Schiller, PhD; James W. Murrough, MD, PhD
Combining Ketamine Infusions and Written Exposure Therapy for Chronic PTSD: An Open-Label Trial.
The Journal of Clinical Psychiatry April 2, 2025
Philip R. Szeszko, Chi C. Chan, Aarthi Ramakrishnan, Mina Rizk, Isabelle Baptista, Sharon Alter, M. Mehmet Haznedar, King-WAi Chu, Hui Xie, Rachel Yehuda, Scott J. Russo, Li Shen, Tia Rizakos, Darwin D.Souza, Lazar Fleysher, Erin A. Hazlett, Marianne Goodman, Cuenghee Kin-Schulze, James W. Murrough
Protein expression in associated with brain white matter in Veterans with Bipolar disorder and suicide attempts
Brain, Behavior, and Immunity October, 2026
Rachel Yehuda, Dennis Charney
Can Psychedelics Help Us Reimagine Prevention of Posttraumatic Stress Disorder?
Biological Psychiatry January, 2026
Niall M. McGowan, James J. Rucker, Rachel Yehuda, Manish Agrawal, Nadav Liam Modlin, Hollie Simmons, Agata Tofil-Kaluza, Shriya Das, and Guy M. Goodwin
Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial
Journal of Psychopharmacology January, 2026
Nadav Liam Modlin,Victoria Williamson,Guy M. Goodwin, Ekaterina Malievskaia, Merve Atli, Zsofia Elek, Alice Gaillard, Don Koelpin, Anthony Cleare, Manish Agrawal, Rachel Yehuda, Namik Kirlic, and James Ruckerd
Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment
eClinical Medicine December, 2025
Amy Lehrner, Thomas B. Hildebrandt and Rachel Yehuda.
Rethinking placebo-controlled clinical trials in psychedelic therapies for psychiatric illness.
The British Journal of Psychiatry 2025
Adriana Feder, MD; Oneysha Brown, BA; Sarah B. Rutter, MA; Leah Cahn, LCSW; Jessica R. Overbey, DrPH; Saren H. Seeley, PhD; Alex Yu, MD; Philip A. Bonanno, MD; Rachel A. Fremont, MD, PhD; Andrew A. Delgado, PhD; Manish K. Jha, MD; Sara Costi, MD; Rachel Yehuda, PhD; Daniela Schiller, PhD; Robert H. Pietrzak, PhD, MPH; Dennis S. Charney, MD; Denise Schiller, PhD; James W. Murrough, MD, PhD
Combining Ketamine Infusions and Written Exposure Therapy for Chronic PTSD: An Open-Label Trial.
The Journal of Clinical Psychiatry April 2, 2025
Leo Sher, Linda M. Bierer, Iouri Makotkine, and Rachel Yehuda.
Progesterone and suicidality in male combat veterans.
QJM An International Journal of Medicine March 24, 2025
Joseph A. Zamaria, Gisele Fernandes-Osterhold, Jonathan Shedler and Rachel Yehuda.
Psychedelics assisting therapy, or therapy assisting psychedelics? The importance of psychotherapy in psychedelic-assisted therapy.
February 5, 2025
Alan K. Davis, PhD, Mark Bates, PhD, Erik M. Lund, MS, Nathan D. Sepeda, BS, Adam W. Levin, MD, Stacey B. Armstrong, PhD, Robert Koffman, MD, Katinka Hooyer, PhD, and Rachel Yehuda, PhD.
The Epidemiology of Psychedelic Use Among United States Military Veterans.
Journal of Psychoactive Drugs June 10, 2024
.
Interplay of combat deployment harassment, testosterone concentrations and post-deployment suicide risk in male veterans.
Acta Neuropsychiatrica March 3, 2024.
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, Josimar Hernandez Antonio, Philip A. Bonanno, Carolyn MacLeod, Charlotte Pierce, Hunter Carney, Morgan T. Morrison, Charles Saylor, George Danias, Lauren Lepow, and Rachel Yehuda.
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.
Bentham Science 2024, 22, 636-735
Charles W. Hoge, MD, KathleenM.Chard, PhD, Rachel Yehuda, PhD
Zachary N. Blalock, Gwyneth W. Y Wu, Daniel Lindqvist, Caroline Trumpff, Janine D. Flory, Jue Lin, Victor I. Reus, Ryan Rampersaud, Rasha Hammamieh, Aarti Gautam, SBPBC, Francis J. Doyle, Charles R. Marmar, Marti Jett, Rachel Yehuda, Owen M. Wolkowitz and Synthia H. Mellon.
Circulating cell-free mitochondrial DNA levels and glucocorticoid sensitivity in a cohort of male veterans with and without combat-related PTSD.
Translational Psychiatry 2024.
.
Bessel A. van der Kolk, Julie B. Wang, Rachel Yehuda, Leah Bedrosian, Allison R. Coker, Charlotte Harrison, Michael Mithoefer, Berra Yazar-Klosinki,
Amy Emerson, Rick Doblin
PLOS ONE January 10, 2024
Carina Seah, Rebecca Signer, Michael Deans, Heather Bader, Tom Rusielewicz, Emily M. Hicks, Hannah Young, Alanna Cote, Kayla Townsley, Changxin Xu, Christopher J. Hunter, Barry McCarthy, Jordan Goldberg, Saunil Dobariya, Paul E. Holtzherimer, Keith A. Young7, NYSCF Global Stem Cell Array® Team, Traumatic Stress Brain Research Group, Scott A. Noggle, John H. Krystal, Daniel Paull, Matthew J. Girgenti, Rachel Yehuda, Kristen J. Brennand, Laura M. Huckins.
Common genetic variation impacts stress response in the brain.
bioRxiv December 28, 2023
Andrew Penn, Rachel Yehuda
Preventing the Gaps in Psychedelic Research from Becoming Practice Pitfalls: A translational Research Agenda.
Psychedelic Medicine December 13, 2023
Lauren Lepow, Hope Kronman and Rachel Yehuda
A Heuristic Approach: Against Consensus Definitions of Psychedelics.
Psychedelic Medicine December 13, 2023
Rachel Yehuda, PhD, and Sidney H. Hankerson, MD, MBA.
Learning From Racial Disparities in COVID-19-Related Stress.
The Amercian Journal of Psychiatry December 1, 2023
Rachel Yehuda, PhD, Amy Lehrner, PhD.
Psychedelic Therapy-A New Paradigm of Care for Mental Health.
JAMA September 5, 2023
TO CONTINUE REVIEWING MATERIAL, PLEASE VISIT DR. YEHUDA’S PUBLICATIONS PAGE